T A Voronina Selected Research

Intraperitoneal Injections

2/2020	Antiexudative Effects of Finasteride and a New Pyrazolo[C]Pyridine Derivative GIZh-72 in Acetic Acid-Induced Experimental Peritonitis.
2/2008	Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T A Voronina Research Topics

Disease

10	Pain (Aches) 01/2023 - 01/2003
8	Hematoma 01/2022 - 05/2003
8	Parkinsonian Disorders (Parkinsonism) 01/2014 - 05/2000
7	Hemorrhagic Stroke 01/2022 - 05/2003
6	Amnesia (Dissociative Amnesia) 04/2010 - 03/2000
5	Brain Ischemia (Cerebral Ischemia) 11/2020 - 09/2002
5	Body Weight (Weight, Body) 09/2017 - 01/2007
5	Schizophrenia (Dementia Praecox) 01/2017 - 11/2003
5	Parkinson Disease (Parkinson's Disease) 01/2012 - 01/2004
4	Hypoxia (Hypoxemia) 02/2015 - 01/2000
3	Epilepsy (Aura) 01/2024 - 01/2002
3	Inflammation (Inflammations) 01/2023 - 01/2005
3	Tremor (Tremors) 01/2006 - 05/2000
2	Visceral Pain 01/2023 - 09/2020
2	Hypothermia 01/2023 - 08/2007
2	Hyperalgesia 01/2023 - 01/2023
2	Cognitive Dysfunction 01/2022 - 01/2017
2	Ischemia 11/2020 - 01/2005
2	Peritonitis 09/2020 - 02/2020
2	Hypercapnia 02/2015 - 01/2012
2	Shock 10/2014 - 03/2005
2	Dyskinesias (Dyskinesia) 01/2014 - 01/2011
2	Weight Loss (Weight Reduction) 01/2013 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 09/2009 - 01/2005
2	Catalepsy 01/2009 - 01/2002
2	Radiation Injuries (Radiation Sickness) 01/2009 - 07/2007
2	Hypokinesia (Bradykinesia) 07/2008 - 01/2006
2	Memory Disorders (Memory Loss) 04/2005 - 01/2000
1	Surgical Wound 01/2023
1	Nociceptive Pain 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Paresis (Hemiparesis) 01/2022
1	Paralysis (Palsy) 01/2022
1	Stroke (Strokes) 11/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020

Drug/Important Bio-Agent (IBA)

12	emoxypine succinateIBA 01/2022 - 01/2002
6	Neuroprotective AgentsIBA 12/2019 - 09/2002
5	Analgesics (Analgesic Drugs)IBA 01/2023 - 03/2005
5	Acetic Acid (Vinegar)FDA LinkGeneric 01/2023 - 09/2007
5	AntibodiesIBA 09/2009 - 01/2003
5	Scopolamine (Hyoscine)FDA Link 09/2009 - 03/2000
4	2- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazoleIBA 12/2019 - 11/2005
4	Anti-Anxiety Agents (Anxiolytics)IBA 01/2017 - 01/2003
4	DipeptidesIBA 02/2015 - 01/2008
4	Levodopa (L Dopa)FDA LinkGeneric 01/2014 - 05/2000
4	hemantaneIBA 01/2014 - 01/2004
4	Nootropic Agents (Nootropics)IBA 01/2013 - 01/2000
4	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2012 - 05/2000
4	NeurotoxinsIBA 01/2012 - 05/2000
4	S100 Proteins (S 100 Protein)IBA 09/2009 - 01/2003
4	Antipsychotic Agents (Antipsychotics)IBA 09/2009 - 01/2005
3	Formaldehyde (Formol)FDA Link 01/2023 - 09/2007
3	AntioxidantsIBA 01/2022 - 01/2002
3	Oxidopamine (6 Hydroxydopamine)IBA 01/2014 - 01/2011
3	Erythropoietin FDA Link 06/2013 - 01/2011
3	Nerve Growth Factor (NGF)IBA 01/2013 - 11/2005
3	N-(2-adamantyl)hexamethylenimineIBA 01/2012 - 03/2001
3	Piracetam (Nootropil)IBA 04/2010 - 01/2000
3	GZR 123IBA 09/2009 - 11/2003
3	nooglutilIBA 01/2004 - 01/2000
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2024 - 10/2014
2	CobaltIBA 01/2024 - 01/2002
2	Therapeutic UsesIBA 01/2023 - 01/2022
2	SolutionsIBA 01/2023 - 11/2005
2	Peptide Hydrolases (Proteases)FDA Link 09/2017 - 11/2007
2	Proline (L-Proline)FDA Link 09/2017 - 11/2007
2	cyclo(prolylglycyl)IBA 02/2015 - 01/2012
2	CyanoacrylatesIBA 06/2013 - 11/2005
2	ethyl phenylacetyl-Pro-GlyIBA 01/2013 - 09/2002
2	Streptozocin (Streptozotocin)FDA Link 01/2013 - 01/2013
2	Amantadine (Aman)FDA LinkGeneric 01/2012 - 01/2011
2	Diazepam (Valium)FDA LinkGeneric 10/2010 - 07/2006
2	Pro-Gly-Pro- ACTH (4-7)IBA 04/2010 - 01/2009
2	Cholinergic Agents (Cholinergics)IBA 09/2009 - 03/2008
2	Apomorphine FDA Link 01/2009 - 01/2002
2	Peptides (Polypeptides)IBA 05/2005 - 03/2005
1	CarrageenanIBA 01/2023
1	ethylmethylhydroxypyridine succinateIBA 01/2023
1	EtoricoxibIBA 01/2023
1	Capsaicin (Zostrix)FDA Link 01/2023
1	Diclofenac (SR 38)FDA LinkGeneric 01/2023
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023
1	N-Methylaspartate (NMDA)IBA 01/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	Ion Channels (Ion Channel)IBA 01/2023
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2023
1	Levetiracetam (Keppra)FDA LinkGeneric 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	prolinalIBA 09/2020
1	Prolyl OligopeptidasesIBA 09/2020
1	Finasteride (Propecia)FDA LinkGeneric 02/2020
1	pyridineIBA 02/2020

Therapy/Procedure

6	Therapeutics 01/2019 - 01/2002
3	Injections 01/2014 - 03/2005
2	Oral Administration 01/2023 - 09/2009
2	Ligation 11/2020 - 01/2009
2	Intraperitoneal Injections 02/2020 - 02/2008
1	Subcutaneous Injections 01/2023